Extracts of Cranberry and Methods of Using Thereof
申请人:Alberte Randall S.
公开号:US20100028469A1
公开(公告)日:2010-02-04
The present disclosure relates in part to extracts of cranberry (
Vaccinium macrocarpon
) comprising an enriched amount of certain compounds having anti-infective activity, e.g. antibacterial and/or antifungal activity, e.g. activity against
C. albicans
. Another aspect of the disclosure relates to combined cranberry and cinnamon extracts. In certain embodiments, these combined extracts have been optimized to control urinary tract infections caused by
E. coli, S. aureus
and
C. albicans
. Certain embodiments of the extract are enriched in bioactive compounds that have been shown to inhibit
C. albicans
adhesion and/or biofilm formation and its growth in vitro. In another aspect of the disclosure, the extracts are enriched in bioactives derived from cranberry and cinnamon that have been shown to inhibit the attachment and the growth of common urinary tract pathogens like
E. coli, S. aureus
and
C. albicans.
Enantioselective Synthesis of Clavaminol A, Xestoaminol C and their Stereoisomers Exhibiting Cytotoxic Activity
However, their preparation in enantiomerically pure forms takes many efforts. Here, we synthetized all stereoisomers of these compounds by application of enantioselective catalysis and we revealed, that more easily available racemic forms exhibit similar cytotoxicity as enantiomerically pure forms.